Biogen Posted September 11, 2026

Senior Director, Immunology Early Development Strategy & Innovation

Cambridge, United States Full time
BD&L & Strategic Planning Immunology Senior Director
Notify me about similar jobs

Biogen is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

About This Role:

The Senior Director, Immunology Early Development Strategy & External Innovation, is a senior scientific and development leader within the Immunology Development Unit, reporting directly to the Vice President, Head of Immunology Early Development Innovation and Strategy. The role serves as a close strategic partner and delegate to the Vice President, with accountability for a Immunology portfolio priorities spanning research-to-development transitions, early clinical development strategy, external innovation, and business development and venture investing assessments.

This leader will connect scientific insight, clinical development judgment, and enterprise strategy to help Biogen identify, shape, and advance differentiated opportunities for patients with immune-mediated diseases. The position is designed for an accomplished bridge builder who earns trust through expertise, judgment, clarity, and follow-through. Success will depend on the ability to align stakeholders, frame consequential choices, and enable cross-functional teams toward high-quality decisions and execution.

The role will work closely with Research, Biomarkers, Clinical Pharmacology, Regulatory, Biostatistics, Clinical Operations, Product Development & Commercialization, Global Commercial, Corporate Strategy, Business Development and External Innovation, and partner companies. Depending on portfolio needs, the Executive Director may lead selected programs or strategic initiatives from preclinical development through proof of biology or proof of concept and contribute to later-stage development planning.

What You’ll Do:

Act as a senior advisor and delegate of the Head of Immunology Early Development Innovation and Strategy, helping shape and execute key portfolio, organizational, and external priorities in Immunology.

Lead the strategy for critical research-to-development transitions, early development planning, and portfolio decisions across selected Immunology programs.

Serve as the delegated clinical development leader for select programs and portfolio initiatives to accelerate value creation.

Drive evaluation of external opportunities for the Immunology Development Unit, integrating scientific, clinical, strategic, and commercial perspectives into meaningful clinical development plans.

Develop evidence-based recommendations for governance and investment decisions, helping senior leaders navigate uncertainty and complexity.

Foster productive collaborations across Research, Development, Commercial, Corporate Strategy, Business Development, and external partners.

Influence and align cross-functional stakeholders to translate strategy into decisive action and execution.

Mentor colleagues and strengthen organizational capability through thought partnership, coaching, and leadership.

Ensure all activities are conducted in accordance with applicable regulatory, quality, ethical, and compliance standards.

Who You Are:

You are a highly credible scientific and drug development leader who can move comfortably between deep scientific discussions on targets and biology, to clinical strategy across indications to portfolio choices and decision-making. You listen carefully, synthesize complex information quickly, and bring structure to uncertain or contested situations. Colleagues seek your perspective because your recommendations are rigorous, balanced, pragmatic, and clear. You create momentum by building shared understanding and commitment across organizational boundaries, not by relying on positional authority.

Required Skills:

MD, MD/PhD, PhD, PharmD, or equivalent doctoral degree in a relevant biomedical discipline.

At least 15 years in pharmaceutical or biotechnology drug development, with progressive leadership responsibilities in research, pharmacology, clinical development, portfolio strategy, or external innovation.

Expertise in immunology and immune-mediated diseases, with experience spanning one or more areas such as rheumatology, dermatology, gastroenterology, allergy, inflammation, or related fields.

Demonstrated experience with multiple therapeutic modalities and driving through key development milestones.

Demonstrated success bridging discovery and translational science to clinical development, including leadership of research-to-development transitions and early development strategies through key value-inflection milestones.

Experience evaluating external opportunities, including business development, licensing, partnerships, venture investments, or strategic collaborations.

Strong understanding of the scientific, clinical, regulatory, and commercial factors that influence development and portfolio decisions.

Demonstrated ability to influence stakeholders up and down the organization and lead across a complex matrixed environment.

Exceptional strategic thinking, judgment, and problem-solving skills, with the ability to make high-quality recommendations and articulate trade-offs in the face of uncertainty.

Excellent communication and executive presence, with the ability to distill complex issues into clear, decision-ready recommendations.

Preferred Skills:

Recognized scientific or development leadership demonstrated through publications, presentations, patents, advisory roles, or equivalent accomplishments.

Experience leading teams through important regulatory milestones in early development (e.g., pre-IND or CTA meetings, clinical hold resolution)

#LI-TD1

Job Level: Management

Additional Information

The base compensation range for this role is: $274,000.00-$377,000.00

Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.

In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being ; including, but not limited to:

Medical, Dental, Vision, & Life insurances

Fitness & Wellness programs including a fitness reimbursement

Short- and Long-Term Disability insurance

A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)

Up to 12 company paid holidays + 3 paid days off for Personal Significance

80 hours of sick time per calendar year

Paid Maternity and Parental Leave benefit

401(k) program participation with company matched contributions

Employee stock purchase plan

Tuition reimbursement of up to $10,000 per calendar year

Employee Resource Groups participation

Why Biogen?

We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.

At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired.  Read on  to learn more about Biogen.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Job details

Seniority
Senior Director
Function
BD&L & Strategic Planning
Therapeutic area
Immunology
Location
Cambridge, United States
Employment type
Full time

How this role compares

Computed from every other active BD&L & Strategic Planning role in our database, not just this employer's listings.

We currently track 129 comparable Senior Director BD&L & Strategic Planning roles across 50 biopharma companies.

129Comparable roles tracked
118Currently active
50Companies hiring similar roles
16Countries represented

Salary context

57 of 129 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Lowest disclosed · Sr. Director - Strategic Alliances (SMDD) · Lilly $151,500/yr – $222,200/yr
Peer group range $186,850 – $380,750 (median $241,313)

Where these roles are based

Top locations among the 129 comparable roles

United States85
China16
Japan4
United Kingdom4
Switzerland3
Netherlands3

+ 10 more countries

Seniority mix

129 of 129 peers have a known seniority level

Director95
Senior Director28
Executive/VP6

Therapeutic area mix

31 of 129 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology10
Immunology9
Neuroscience8
Respiratory2
Vaccines & Infectious Disease1
Dermatology & Aesthetics1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

100%similar
Johnson & Johnson New Brunswick, United States Senior Director
Same function Same therapeutic area Same seniority Same country
90%similar
Regeneron Pharmaceuticals, Inc (USA) Tarrytown, United States Executive/VP
Same function Same therapeutic area Adjacent seniority Same country
85%similar
Johnson & Johnson Shanghai, China Senior Director
Same function Same therapeutic area Same seniority
85%similar
Johnson & Johnson Chiyoda, Japan Senior Director
Same function Same therapeutic area Same seniority
75%similar
Regeneron UK Limited Uxbridge1, United Kingdom Director
Same function Same therapeutic area Adjacent seniority
75%similar
Regeneron GmbH Munich, Germany Director
Same function Same therapeutic area Adjacent seniority

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

Or follow a whole field: get every new BD&L & Strategic Planning job in the United States, and choose locations and companies.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

100%
Senior Director, Business Development, Immunology Acquisitions
Johnson & Johnson · New Brunswick, United States · Senior Director
Function Therapeutic area Seniority Country
85%
[Innovative Medicine] Senior Director, Head of New Business Development, Japan (including Immunology)
Johnson & Johnson · Chiyoda, Japan · Senior Director
Function Therapeutic area Seniority Country
75%
Director International Commercialization Immunology
Regeneron Spain S.L.U. · Madrid, Spain · Director
Function Therapeutic area Adjacent seniority Country
60%
Sr. Director - Strategic Alliances (SMDD)
Lilly · Indianapolis, Indiana, United States of America · Senior Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.